首页> 外国专利> METHOD AND KIT FOR THE DETECTION OF HEPARIN-DEPENDENT ANTIBODIES AND THE DIAGNOSIS OF IMMUNE OR AUTOIMMUNE PATHOLOGIES POTENTIATED BY HEPARIN SUCH AS HEPARIN-INDUCED THROMBOCYTOPENIA

METHOD AND KIT FOR THE DETECTION OF HEPARIN-DEPENDENT ANTIBODIES AND THE DIAGNOSIS OF IMMUNE OR AUTOIMMUNE PATHOLOGIES POTENTIATED BY HEPARIN SUCH AS HEPARIN-INDUCED THROMBOCYTOPENIA

机译:检测肝素依赖性抗体和诊断肝素引起的血小板减少症的免疫或自身免疫病的方法和试剂盒

摘要

The invention relates to a method for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by a heparin substance, such as thrombocytopenia induced by heparin (HIT type II) as inducer drug. The invention is characterized in that said method comprises the steps consisting in: 1) reacting: at least one substance with high affinity for a heparin substance (SFA), consisting of any molecule or complex having a high affinity for a heparin substance, with at least one heparin substance (SH) so as to form a substance with high affinity for heparin-heparin substance (SFA-SH) complex, wherein the heparin substance is in slight or large excess, so as to be able to bind other substances with affinity for heparin; then with at least one potential antigenic substance capable of reacting with the heparin substance, thus forming a complex (Ag-SH); and, finally, with the plasma or the serum of a patient to be tested (preferably diluted to a dilution of the order of 1:100) potentially containing: an anti(Ag-SH) antibody material generated in the organism after administration of a heparin substance, and/or at least one immune complex consisting of an Ag-SH/anti(Ag-SH) antibody complex present in the plasma or serum of the patient capable of reacting with the substance with high affinity for the heparin substance-heparin substance (SFA-SH) complex, and then, 2) revealing the resulting (Ag-SH)-anti(Ag-SH) complex produced.
机译:本发明涉及一种检测肝素依赖性抗体和诊断由肝素物质增强的免疫或自身免疫病理学的方法,例如由肝素诱导的血小板减少症(HIT II型)作为诱导药物。本发明的特征在于,所述方法包括以下步骤:1)使至少一种对肝素物质(SFA)具有高亲和力的物质与对肝素物质具有高亲和力的任何分子或复合物进行反应。至少一种肝素物质(SH),以形成对肝素-肝素物质(SFA-SH)复合物具有高亲和力的物质,其中肝素物质略有或大量过量,从而能够与其他物质亲和结合肝素然后与至少一种能够与肝素物质反应的潜在抗原物质,从而形成复合物(Ag-SH);最后,用待测患者的血浆或血清(最好稀释至1:100的稀释度)来潜在地含有:施用抗微生物剂后在生物体内产生的抗(Ag-SH)抗体材料肝素物质,和/或存在于患者血浆或血清中的至少一种由Ag-SH /抗(Ag-SH)抗体复合物组成的免疫复合物,能够与对肝素物质-肝素具有高亲和力的物质反应物质(SFA-SH)复合物,然后2)揭示生成的生成的(Ag-SH)-抗(Ag-SH)复合物。

著录项

  • 公开/公告号EP2030017B1

    专利类型

  • 公开/公告日2012-04-18

    原文格式PDF

  • 申请/专利权人 HYPHEN BIOMED;

    申请/专利号EP20070788927

  • 发明设计人 VISSAC ANNE-MARIE;AMIRAL JEAN;

    申请日2007-06-25

  • 分类号G01N33/53;G01N33/543;C12Q1/56;G01N33/86;

  • 国家 EP

  • 入库时间 2022-08-21 17:16:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号